Jared Whitlock
Reporter
Phone: 858-634-4636 Extension: 3130
Recent Stories
Evofem’s Gel Lessens Risk of Chlamydia, Gonorrhea in Clinical Trial
Evofem Biosciences’ gel in mid-stage clinical trials reduced the risk of chlamydia and gonorrhea infections compared to a placebo, the San Diego company reported Dec. 2.
Phoenix Molecular’s Seed Funding Reaches $12 Million
Co. Targets RSK2 Enzyme Often Found in Breast Cancers
Phoenix Molecular Designs is attacking advanced breast cancer in a new way — and with added funding.
Avidity Gets $100M For Research Into Muscle Disorders
More Than a Dozen Entities Invest in Preclinical Programs
Avidity Biosciences recently was awarded a $100 million series C round.
Truvian Seeks to Decentralize Blood Testing
BIOTECH: Co. Aims for Transparency in Each Step
Truvian Sciences wants to run a battery of tests on only drops of blood. Its mobile lab is designed to return answers in 20 minutes.
Radys Pledge $200M to Children’s Hospital
PHILANTHROPY: Gift For Expansion and Integrating Care and Tech
Rady Children’s Hospital in San Diego recently announced the single largest donation in its history.
Canale Communications Acquired in Deal Worth up to $31M
UGD Healthcare bought Canale Communications, a San Diego firm that specializes in strategy consulting for life sciences companies, it was announced Nov. 26.
Presidium Health Raises $3.5 Million To Reduce ER Visits
Co. Has Launched A Mobile Health Team In San Diego
Seniors and patients with chronic conditions are more likely to cycle through emergency rooms.
It’s Mirati Vs. Amgen As Drugmakers Target Mutated Gene
Bigger Sample Size, More Time Needed To Evaluate Drugs
An experimental drug from Mirati Therapeutics shrunk the tumors of some cancer patients with a common mutation, in an early-stage clinical trial.
Rady Children’s to Receive $200M Donation
Rady Children’s Hospital in San Diego recently announced the single largest donation in its history.
Funding Goes to Cancer Drug Developers, Company Billed as the Anti-Theranos
Seeking and destroying lung cancer. Succeeding where Theranos failed. Treating resistant breast cancers.